Trade

with

Allergan Inc
(NYSE: AGN)
AdChoices
182.81
-3.35
-1.80%
After Hours :
183.65
+0.84
+0.46%

Open

187.00

Previous Close

186.16

Volume (Avg)

2.23M (2.31M)

Day's Range

182.77-187.08

52Wk Range

88.34-192.98

Market Cap.

54.33B

Dividend Rate (Yield )

0.20 (0.11%)

Beta

0.73

Shares Outstanding

297.18M

P/E Ratio (EPS)

41.84 (4.26)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 6.30B

    • Net Income

    • 985.10M

    • Market Cap.

    • 54.33B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 19.06

    • PEG (Price/Earnings Growth) Ratio

    • 0.71

    • Beta

    • 0.73

    • Forward P/E

    • 22.22

    • Price/Sales

    • 8.33

    • Price/Book Value

    • 8.15

    • Price/Cash flow

    • 31.25

      • EBITDA

      • 2.06B

      • Return on Capital %

      • 12.46

      • Return on Equity %

      • 20.58

      • Return on Assets %

      • 12.46

      • Book Value/Share

      • 22.83

      • Shares Outstanding

      • 297.18M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.05 (8/13/2014)

      • Dividend Declaration Date

      • 7/21/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 205.67

        • Credit Rating

        • UR-

        • Analysts

        • 5

        • EPS Estimate

        • 7.92

        • Cashflow Estimate

        • 8.62

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 16.70

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • 15.50

          • -26.33

          • Net Income

            Q/Q (last year)

          • 18.30

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 7.43

          • -5.42

          • Net Income

            5-Year Annual Average

          • 17.00

          • 3.16

          • Dividends

            5-Year Annual Average

          • 0.00

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 87.81

            • 64.72

            • Pre-Tax Margin

            • 27.15

            • 13.77

            • Net Profit Margin

            • 19.06

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 85.80

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 20.00

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 13.10

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.31

              • 0.33

              • Current Ratio

              • 4.05

              • 1.52

              • Quick Ratio

              • 3.39

              • 0.87

              • Interest Coverage

              • 26.12

              • 6.77

              • Leverage Ratio

              • 1.62

              • 1.91

              • Book Value/Share

              • 22.83

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 40.98

                • 63.69

                • P/E Ratio 5-Year High

                • 44.20

                • 237.47

                • P/E Ratio 5-Year Low

                • 12.21

                • 19.71

                • Price/Sales Ratio

                • 8.03

                • 3.64

                • Price/Book Value

                • 7.85

                • 3.39

                • Price/Cash Flow Ratio

                • 31.25

                • 21.79

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 4.58

                    • Dividend Date

                    • 7/21/2014

                    • Ex-Dividend Date

                    • 8/13/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 20.58

                        (13.70)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • 12.46

                        (8.40)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • 15.93

                        (11.10)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • 110.97k

                      • 27.79k

                      • Inventory Turnover

                      • 2.87

                      • 1.80

                      • Asset Turnover

                      • 0.65

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      1.81B
                      Operating Margin
                      28.72
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      31.25
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      46.82%

                      Mutual Fund Ownership

                      34.21%

                      Float

                      99.79%

                      5% / Insider Ownership

                      0.18%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        5,034,771

                      • 4.18

                      • 1.69

                      • Vanguard Five Hundred Index Fund

                      •  

                        3,085,222

                      • 0.11

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        3,010,652

                      • -1.19

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        2,898,601

                      • -2.11

                      • 0.98

                      • Parnassus Core Equity Fund

                      •  

                        2,695,000

                      • 0.00

                      • 0.91

                      • T. Rowe Price Capital Appreciation Fund

                      •  

                        2,359,705

                      • -6.92

                      • 0.79

                      • T. Rowe Price Blue Chip Growth Fund

                      •  

                        1,757,500

                      • 126.19

                      • 0.59

                      • T. Rowe Price Health Sciences Fund

                      •  

                        1,622,800

                      • 114.57

                      • 0.55

                      • Vanguard Growth Index Fund

                      •  

                        1,512,809

                      • 3.67

                      • 0.51

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Biovail Corp

                      •  

                        28,878,638

                      • +28,878,538.00%

                      • 9.72

                      • Pershing Square Capital Management, L.p.

                      •  

                        28,878,638

                      • 0.00%

                      • 9.72

                      • T. Rowe Price Associates, Inc.

                      •  

                        15,919,404

                      • +109.66%

                      • 5.36

                      • Vanguard Group, Inc.

                      •  

                        15,179,657

                      • +1.36%

                      • 5.11

                      • State Street Corp

                      •  

                        12,840,057

                      • +5.84%

                      • 4.32

                      • State Farm Mutual Automobile Ins CO

                      •  

                        10,526,400

                      • 0.00%

                      • 3.55

                      • BlackRock Fund Advisors

                      •  

                        10,048,474

                      • +10.90%

                      • 3.38

                      • Jennison Associates LLC

                      •  

                        4,487,566

                      • -57.92%

                      • 1.51

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Aggressive Growth

                      Style

                      Large Growth

                      Allergan Inc was founded in 1950 and incorporated in Delaware in 1977. The Company is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices that enable people t...moreo live life to its greatest potential. The Company discovers, develops and commercializes specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets. It is engaged in specialty pharmaceutical, biologic and medical device research and development, with global efforts targeting products and technologies related to eye care, skin care, neuromodulators, medical aesthetics, obesity intervention, urology and neur...moreology. The Company operates its business on the basis of two reportable segments specialty pharmaceuticals and medical devices. The specialty pharmaceuticals segment produces a broad range of pharmaceutical products, including: ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease; Botox® for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and other prescription and over-the-counter skin care products; and urologics products. The medical devices segment produces a broad range of medical devices, including: breast implants for augmentation, revision and reconstructive surgery and tissue expanders; and facial aesthetics products. The Company provides marketing strategy teams to ensure development and execution of a consistent marketing strategy for its products in all geographic regions that share similar distribution channels and customers. The Company faces intense competition from generic drug manufacturers in the United States and internationally. The Company is subject to federal, state, local and foreign environmental laws and regulations.lessless

                      Key People

                      David E.I. Pyott

                      CEO/Chairman of the Board/Director

                      Mr. James M. Hindman

                      Executive VP, Divisional/CFO

                      Mr. Arnold A. Pinkston

                      Assistant Secretary/Executive VP/General Counsel

                      Raymond H. Diradoorian

                      Executive VP, Divisional

                      Dr. Scott M. Whitcup,M.D.

                      Chief Scientific Officer/Executive VP, Divisional

                      • Allergan Inc

                      • 2525 Dupont Drive

                      • Irvine, CA 92612

                      • USA.Map

                      • Phone: +1 714 246-4500

                      • Fax: +1 714 246-4971

                      • allergan.com

                      Incorporated

                      1977

                      Employees

                      11,600

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: